Your account is not claimed yet. You can sign up with ORCID to claim your account.

Subramaniam Malarkannan

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 12

Top Venues

Cells

eLife

Cancer immunology research

Genome medicine

Medical College of Wisconsin (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Medical College of Wisconsin Apr 1o 2000

United States

PHD :: Medicine

Publications

Mohamed Khalil, Subramaniam Malarkannan
Innatus immunis: Evolving paradigm of adaptive NK cells. The Journal of experimental medicine 219 (11) (2022)
Kawaljit Kaur, Po-Chun Chen, Meng-Wei Ko, Ao Mei, Nishant Chovatiya, Sara Huerta-Yepez, Weiming Ni, Sean Mackay, Jing Zhou, Dipanarine Maharaj, Subramaniam Malarkannan, Anahid Jewett
The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Cells 11 (21) (2022)
Dandan Wang, Subramaniam Malarkannan
Transcriptomic perspectives of memory-like NK cells and aging. Genome medicine 14 (1) (2022)
Arash Nanbakhsh, Subramaniam Malarkannan
The Role of microRNAs in NK Cell Development and Function. Cells 10 (8) (2021)
Mohamed Khalil, Dandan Wang, Elaheh Hashemi, Scott S Terhune, Subramaniam Malarkannan
Implications of a 'Third Signal' in NK Cells. Cells 10 (8) (2021)
Subramaniam Malarkannan
NKG7 makes a better killer. Nature immunology 21 (10) (2020)
Chao Yang, Jason R Siebert, Robert Burns, Yongwei Zheng, Ao Mei, Benedetta Bonacci, Demin Wang, Raul A Urrutia, Matthew J Riese, Sridhar Rao, Karen-Sue Carlson, Monica S Thakar, Subramaniam Malarkannan
Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature. eLife 9 (2020)
Pawan Kumar, Kamalakannan Rajasekaran, Arash Nanbakhsh, Jack Gorski, Monica S Thakar, Subramaniam Malarkannan
IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection. Scientific reports 9 (1) (2019)
Wenwen Xu, Juan Dong, Yongwei Zheng, Juan Zhou, Ying Yuan, Hieu Minh Ta, Halli E Miller, Michael Olson, Kamalakannan Rajasekaran, Marc S Ernstoff, Demin Wang, Subramaniam Malarkannan, Li Wang
Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression. Cancer immunology research 7 (9) (2019)
Arash Nanbakhsh, Anupallavi Srinivasamani, Sandra Holzhauer, Matthew J Riese, Yongwei Zheng, Demin Wang, Robert Burns, Michael H Reimer, Sridhar Rao, Angela Lemke, Shirng-Wern Tsaih, Michael J Flister, Shunhua Lao, Richard Dahl, Monica S Thakar, Subramaniam Malarkannan
Mirc11 Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells. Cancer immunology research 7 (10) (2019)
Chao Yang, Jason R Siebert, Robert Burns, Zachary J Gerbec, Benedetta Bonacci, Amy Rymaszewski, Mary Rau, Matthew J Riese, Sridhar Rao, Karen-Sue Carlson, John M Routes, James W Verbsky, Monica S Thakar, Subramaniam Malarkannan
Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nature communications 10 (1) (2019)
Chao Yang, Shirng-Wern Tsaih, Angela Lemke, Michael J Flister, Monica S Thakar, Subramaniam Malarkannan
mTORC1 and mTORC2 differentially promote natural killer cell development. eLife 7 (2018)

Subramaniam Malarkannan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Subramaniam Malarkannan